ENDRA Life Sciences (NDRA) Amortization of Deferred Charges (2016)
ENDRA Life Sciences' (NDRA) quarterly Amortization of Deferred Charges came in at $338164.0 in Q4 2016, down 2.3% quarter-over-quarter from $346119.0 in Q3 2016.
Analysis
ENDRA Life Sciences (NDRA) Amortization of Deferred Charges (2016) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Amortization of Deferred Charges for 1 consecutive years, with $338164.0 the latest figure, recorded in Q4 2016.
- On a quarterly basis, Amortization of Deferred Charges changed N/A year-over-year to $338164.0 in Q4 2016; TTM through Dec 2017 was $684283.0, a N/A change from a year earlier, with the FY2020 full-year figure at $232426.0, down 90.13% from the prior year.
- Amortization of Deferred Charges was $338164.0 for Q4 2016 at ENDRA Life Sciences, down from $346119.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $346119.0 in Q3 2016 and troughed at $338164.0 in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - |